Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
T&R Biofab Co. Ltd. manages a patent portfolio in the Chemistry & Materials technology area with 3 pending office actions currently under review. The data shows that these matters are distributed across 3 distinct art units, which suggests that the pending applications cover a variety of technical subjects within the field. This distribution requires the applicant to address the specific standards and guidelines of 3 different administrative divisions.
The prosecution involves 3 distinct examiners, meaning that each pending matter is being evaluated by a different individual. LIANG, SHIBIN is the busiest examiner for this portfolio, currently handling 1 pending office action. Because no single examiner is responsible for more than 1 pending office action, the prosecution strategy must be tailored to the individual preferences and examination styles of 3 separate people.
The lack of overlap among the 3 distinct examiners and 3 distinct art units indicates a decentralized prosecution environment. Insights gained from one of the 3 pending office actions may not be applicable to the others. Practitioners should focus on the unique technical requirements of each art unit and the specific feedback from each examiner to move the portfolio forward effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIANG, SHIBIN | 1 | 62.8% | +17.0% |
| NERENBERG, RENEE FLORENCIA | 1 | 66.7% | +0.0% |
| EBBINGHAUS, BRIANA NOEL | 1 | 61.6% | +63.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558509 | LOCAL HEATING TYPE THREE-DIMENSIONAL (3D) PRINTER HEAD | LIANG, SHIBIN | — |
| 18470567 | BIOPRINTED SOFT TISSUE REINFORCEMENT SCAFFOLD | NERENBERG, RENEE FLORENCIA | — |
| 17626100 | LIVER ORGANOID AND PREPARATION METHOD THEREFOR | EBBINGHAUS, BRIANA NOEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558509 | LOCAL HEATING TYPE THREE-DIMENSIONAL (3D) PRINTER HEAD | LIANG, SHIBIN | — |
| 17626100 | LIVER ORGANOID AND PREPARATION METHOD THEREFOR | EBBINGHAUS, BRIANA NOEL | — |
| Art Unit | Apps |
|---|---|
| 1700 | 1 |
| 3774 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18558509 | LOCAL HEATING TYPE THREE-DIMENSIONAL (3D) PRINTER HEAD | LIANG, SHIBIN | 1700 | §103§112 | Final Rejection | — | Pending | Nov 01, 2023 |
| 18470567 | BIOPRINTED SOFT TISSUE REINFORCEMENT SCAFFOLD | NERENBERG, RENEE FLORENCIA | 3774 | §102§103 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 17626100 | LIVER ORGANOID AND PREPARATION METHOD THEREFOR | EBBINGHAUS, BRIANA NOEL | 1632 | §103§112 | Non-Final OA | — | Pending | Jan 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial